Menu

Recent Interviews

Jerre Foo, Corporate Development Executive, Silkroad Nickel

Jerre Foo
Corporate Development Executive | Silkroad Nickel
50 Armenian Street #03-04, 179938 Singapore (SGP)

enquiries@silkroadnickel.com

+65 6327 8971

Silkroad Nickel: 'The course is set for dynamic profit growth.'


Dr. Thomas Gutschlag, CEO, Deutsche Rohstoff AG

Dr. Thomas Gutschlag
CEO | Deutsche Rohstoff AG
Q7, 24, 68161 Mannheim (D)

info@rohstoff.de

+49 621 490 817 0

Interview Deutsche Rohstoff AG: "We can imagine additional investments in the field of electromobility."


Steve Cope, President, CEO and Director, Silver Viper

Steve Cope
President, CEO and Director | Silver Viper
1055 W Hastings St Suite 1130, V6E 2E9 Vancouver (CAN)

info@silverviperminerals.com

+1-604-687-8566

Interview with Silver Viper: Future price drivers and takeover fantasy


14. April 2020 | 10:47 CET

Airbus, Royal Dutch Shell, Triumph Gold - Identifying and taking advantage of opportunities

  • Investments
Photo credits: pixabay.com

Globalisation is a competition with different interests. Access to knowledge and raw materials as well as a certain vertical range of manufacturing play an important role. Over many decades, the USA and Europe have occupied various leading positions in the field of role allocation. With the outbreak of the current Corona Crisis, the cards are being reshuffled. The dependence on China has grown to such an extent that the rest of the world is simply dependent on supplies from Asia. Supply chains to Asia are becoming a threat to the global balance. The need for action is obvious.

time to read: 1 minutes by Mario Hose


 

Author

Mario Hose

Born and raised in Hannover, Lower Saxony follows social and economic developments around the globe. As a passionate entrepreneur and columnist he explains and compares the most diverse business models as well as markets for interested stock traders.

About the author


Strengthen Europe's aircraft manufacturers

The European aircraft manufacturer Airbus Group cannot escape the effects of the global Corona Pandemic. Similar to its competitor Boeing, the share has been trading at a low level for several weeks. In February 2020, Airbus shares still cost more than EUR 137.00. Subsequently, the share price slipped to below EUR 50.00. Currently, the share is trading above EUR 60.00 again, bringing the company's valuation to over EUR 47 billion. During the same period, Boeing's share price collapsed from over USD 347.00 to below USD 96.00. At yesterday's closing price of around USD 147.00, the company is again valued at USD 83 billion.

Oil and ESG

The oil producer Royal Dutch Shell also recorded sharp price declines since the beginning of the year. The value of the shares has fallen from over EUR 27.00 to below EUR 11.00. At the current level of EUR 17.50, the company is valued at around EUR 135 billion. The stock of the Canadian oil producer Saturn Oil & Gas closed yesterday at CAD 0.11. The share price peaked at CAD 0.165 at the beginning of the year. The company is currently valued at around CAD 26 million and recently announced that around half of its output has been sold at a price of over CAD 65.00 per barrel by February 2021. The production of oil from countries where human rights and the environment are protected is becoming increasingly important in a better world.

Gold for diversification

Triumph Gold is a Canadian gold company focused on the exploration of its own areas in the Yukon. In the past, Triumph Gold has made numerous discoveries and Newmont Mining is one of the major shareholders of the listed company. Due to the recent development of the gold price to more than USD 1,700 per troy ounce, it can be expected that Triumph Gold will sooner or later become the focus of investors and potential buyers. At yesterday's closing price of CAD 0.17, the market capitalization is around CAD 18 million. Gold is one of the oldest and most secure currencies for investors in uncertain times.


Author

Mario Hose

Born and raised in Hannover, Lower Saxony follows social and economic developments around the globe. As a passionate entrepreneur and columnist he explains and compares the most diverse business models as well as markets for interested stock traders.

About the author



Conflict of interest & risk note

In accordance with §34b WpHG we would like to point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH may hold long or short positions in the aforementioned companies and that there may therefore be a conflict of interest. Apaton Finance GmbH may have a paid contractual relationship with the company, which is reported on in the context of the Apaton Finance GmbH Internet offer as well as in the social media, on partner sites or in e-mail messages. Further details can be found in our Conflict of Interest & Risk Disclosure.


Related comments:

20. April 2021 | 09:45 CET | by Stefan Feulner

Varta, Sierra Growth, CureVac - Clear signals!

  • Investments

Sometimes, for various reasons, it takes longer before the positive developments of a Company are absorbed by the market and thus provide for price gains. It is currently similar to the precious metal gold, which is still in the consolidation phase. The facts such as national debt, inflation fears and the ultra-loose monetary policy of the central banks speak another clear language.

Read

20. April 2021 | 07:10 CET | by Carsten Mainitz

BioNTech, SunMirror, Steinhoff - Great News!

  • Investments

Shortly before the finish line, the going gets tough again. Many athletes and those who have to really "bite" in the last few meters before a deadline are probably familiar with this feeling. Everyday life in the Corona pandemic is also becoming more exhausting. Now, with BioNTech's announcement that it will double weekly vaccine dose deliveries to around 5.1 million units from the end of May, there may be a breakthrough in achieving herd immunity in Germany in the next few months. It is not only good news for the Company's shareholders but everyone. Below we present two other companies whose shareholders should be very pleased. Let us surprise you!

Read

15. April 2021 | 07:15 CET | by Stefan Feulner

Alibaba, The Place Holdings, CureVac - Great opportunities lie here!

  • Investments

The German vaccination disaster is going into the next round. After the AstraZeneca vaccine's back and forth and the question of whether only younger people, older people or no one should be vaccinated with the vaccine, the American vaccine manufacturer Johnson & Johnson is now experiencing delivery stoppages. The return to "normality" once again seems to be a long way off. Another question to ask yourself. What will future life in the new normal look like in the hard-pressed inner cities?

Read